Fig. 2From: Sodium-glucose co-transporter 2 inhibitor use in patients with diabetes mellitus undergoing endovascular therapy for symptomatic peripheral artery diseasePrimary patency (freedom from restenosis) in the propensity score-matched population. Dotted lines indicate 95% confidence intervals. SE, standard error; SGLT2, sodium-glucose co-transporter 2Back to article page